Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mattias Hammarström

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of the National Cancer Institute|July 2, 2025
Response to Zhu, Jiang, and ZhuMattias Hammarström, Per Hall
Lakartidningen|September 9, 2021
[It is time for individual breast cancer prevention]Per Hall, Mattias Hammarström, Roxanna Hellgren
International Journal of Epidemiology|February 10, 2017
Cohort Profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA)Marike Gabrielson, Mikael Eriksson, Mattias Hammarström, et al.
The Oncologist|May 23, 2022
Topical Endoxifen for Mammographic Density Reduction-A Randomized Controlled TrialMagnus Bäcklund, Mikael Eriksson, Marike Gabrielson, et al.
International Journal of Cancer|March 30, 2024
Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density changeMarike Gabrielson, Mattias Hammarström, Jenny Bergqvist, et al.
Journal of the National Cancer Institute|May 3, 2026
Endoxifen for mammographic density reduction-results from the KARISMA endoxifen trialPer Hall, Mattias Hammarström, Jenny Bergqvist, et al.
BMC Health Services Research|March 5, 2025
Evaluation of a digital reporting and supporting tool in breast cancer prevention trials (KarmApp)José Tapia, Marike Gabrielson, Mattias Hammarström, et al.
International Journal of Cancer|January 13, 2023
Effects of tamoxifen on normal breast tissue histological composition: Results from a randomised six-arm placebo-controlled trial in healthy womenMarike Gabrielson, Mattias Hammarström, Magnus Bäcklund, et al.
The Oncologist|May 23, 2022
Time to Mammographic Density Decrease After Exposure to TamoxifenMagnus Bäcklund, Mikael Eriksson, Mattias Hammarström, et al.
BMC Cancer|March 27, 2020
European women's perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative studyLinda Rainey, Daniëlle van der Waal, Anna Jervaeus, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of the National Cancer Institute|July 2, 2025
Response to Zhu, Jiang, and ZhuMattias Hammarström, Per Hall
Lakartidningen|September 9, 2021
[It is time for individual breast cancer prevention]Per Hall, Mattias Hammarström, Roxanna Hellgren
International Journal of Epidemiology|February 10, 2017
Cohort Profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA)Marike Gabrielson, Mikael Eriksson, Mattias Hammarström, et al.
The Oncologist|May 23, 2022
Topical Endoxifen for Mammographic Density Reduction-A Randomized Controlled TrialMagnus Bäcklund, Mikael Eriksson, Marike Gabrielson, et al.
International Journal of Cancer|March 30, 2024
Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density changeMarike Gabrielson, Mattias Hammarström, Jenny Bergqvist, et al.
Journal of the National Cancer Institute|May 3, 2026
Endoxifen for mammographic density reduction-results from the KARISMA endoxifen trialPer Hall, Mattias Hammarström, Jenny Bergqvist, et al.
BMC Health Services Research|March 5, 2025
Evaluation of a digital reporting and supporting tool in breast cancer prevention trials (KarmApp)José Tapia, Marike Gabrielson, Mattias Hammarström, et al.
International Journal of Cancer|January 13, 2023
Effects of tamoxifen on normal breast tissue histological composition: Results from a randomised six-arm placebo-controlled trial in healthy womenMarike Gabrielson, Mattias Hammarström, Magnus Bäcklund, et al.
The Oncologist|May 23, 2022
Time to Mammographic Density Decrease After Exposure to TamoxifenMagnus Bäcklund, Mikael Eriksson, Mattias Hammarström, et al.
BMC Cancer|March 27, 2020
European women's perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative studyLinda Rainey, Daniëlle van der Waal, Anna Jervaeus, et al.
Pageof 2